IOMED

Biotech & Life Sciences · Barcelona, Spain · Founded 2016

Empowering Healthcare Data MoreLess

A healthcare platform, aligned with the European Health Data Spaces, created to enable Hospitals and Healthcare Systems to mediate health data for secondary use.

We aim to lay the foundation for data-driven medicine and ensure that medical practice is based on evidence and real-world data.

Valuation $0–100M

Revenue <$1M

Headcount <100

Total funding $10–50M

Unlock exact values

Company overview

IOMED company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2016
Headquarters: Barcelona, Spain
Employees: 42
Open positions: None listed
Dealroom signal: 61.5

Website ↗LinkedIn ↗X ↗

client focusb2btechnologyArtificial IntelligencetechnologyBig DatatechnologyDeep TechtechnologyMachine LearningtechnologyDeep Learningsub industryBioTechnologysub industryHealth Platformbusiness modelSaaSindustryHealthsectorPredictive AnalyticssectorDeveloper ToolssectorAPIsectorCore AI

Valuation & funding

IOMED funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Sep 2023	$1.1M	—	Red.es	↗
SERIES A✓Equity / VC	Sep 2023	$11M	$44M	Adara Ventures · Redseed · Easo Ventures · XTX Ventures	↗
SEED✓Equity / VC	Sep 2020	$2.2M	$8.8M	Adara Ventures	—
SEED✓Equity / VC	Jul 2018	$550K	$2.2M	Inveready · Easo Ventures · Pioneers Ventures · Speedinvest	↗
GRANT✓Other financing	Nov 2016	$55K	—	Undisclosed	—
SEED✓Equity / VC	Mar 2016			Undisclosed	—

Showing 6 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin
2026	$427K	0%	−$299K	-69.9%	−$2.6M	-619.7%
2025	$427K	0%	−$299K	-69.9%	−$2.6M	-619.7%
2024	$427K	0%	−$299K	-69.9%	−$2.6M	-619.7%
2023	$427K	-17.3%	−$299K	-69.9%
2022	$516K	+37.4%	−$299K	-57.8%
2021	$376K	+314.6%	−$299K	-79.5%
2020	$91K	—	−$247K	-272.8%

Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

IOMED website traffic

Latest recorded traffic for IOMED is 4K monthly website visits, up 809.1% over the last three months. IOMED's team declined 12.5% over the past year.

Latest monthly visits4K 3-month web change+809.1% 1-year team growth-12.5%

Monthly website visits73 observations · Oct 2017–Nov 2023

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

IOMED compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ARArkhnHelp hospitals managing and leveraging their data	Paris, France	Operational	27	$4.4M	$18M
CICIBILTECHProvides a prediction of kidney allograft survival, enabling clinicians to anticipate patient health outcomes, improving medical decisions through personalized treatments	Paris, France	Operational
IDIdovenAI-powered platform for rapid, accurate electrocardiogram analysis	Majadahonda, Spain	Operational
KTKheiron Medical TechnologiesHelps radiologists detect breast cancer earlier using deep learning	London, United Kingdom	Acquired
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational
QUQuibimProducer of whole body radiological image analysis based on Artificial Intelligence	Valencia, Spain	Operational
ICIcometrixAI-powered software for quantitative brain scan analysis	Leuven, Belgium	Acquired
GLGleamerProviding imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications	Saint-Mandé, France	Acquired

Showing 8 of the closest matchesCompare every metric →

Talent graph

IOMED's talent

Book a demo to see the people

Team profiled 9 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on IOMED's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 6 investors entered at this stage

Inveready

Easo Ventures

Speedinvest

Pioneers Ventures

Adara Ventures

Red.es

Series A 4 investors entered at this stage

Redseed

XTX Ventures

Philips Ventures

Fondo Bolsa Social

Other known 6 additional known investors

Alexandre Perrin

Arnaud Bakker

BIND - Basque Open Innovation Platform

Cuatrecasas Acelera

Future4Care

Stellum Capital

Global footprint

Where IOMED has talent and traffic

Workforce by country

6 countries with
team presence

🇪🇸 Spain75%

🇸🇪 Sweden7.1%

🇬🇧 United Kingdom3.6%

🇵🇹 Portugal3.6%

🇨🇱 Chile3.6%

Top 5 of 6 shown

In the news

Latest news about IOMED

Recent press, funding announcements, and product moves mentioning IOMED — open to read from the original sources.

See all news

Market sentiment

What the market is saying about IOMED

An AI-synthesized read of the highest-engagement posts about IOMED on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See IOMED’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.